- Report
- October 2024
- 191 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
- 307 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- October 2024
- 295 Pages
Global
From €1355EUR$1,475USD£1,100GBP
- Report
- July 2024
- 153 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- September 2024
- 106 Pages
Global
From €4706EUR$4,950USD£3,953GBP
€5229EUR$5,500USD£4,393GBP
- Report
- December 2024
- 168 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- November 2024
- 312 Pages
Global
From €3969EUR$4,175USD£3,334GBP
- Report
- March 2025
- 187 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 250 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 392 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP

The Third Generation Sequencing market within the Biotechnology industry is a rapidly growing sector. It is a technology that enables the sequencing of entire genomes in a single run, allowing for the analysis of complex genomes and the identification of genetic variants. This technology has enabled researchers to gain a better understanding of the genetic basis of diseases, as well as to develop new treatments and diagnostics. It has also enabled the development of personalized medicine, allowing for the development of treatments tailored to an individual's genetic makeup.
The Third Generation Sequencing market is driven by the increasing demand for personalized medicine, as well as the need for more accurate and efficient sequencing technologies. This has led to increased investment in the sector, with many companies developing new technologies and products. Some of the major players in the market include Illumina, Pacific Biosciences, Oxford Nanopore Technologies, 10X Genomics, and BGI. Show Less Read more